Literature DB >> 1330425

Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.

C Buonavoglia1, M Tollis, D Buonavoglia, A Puccini.   

Abstract

The AA reports the results of vaccination against canine parvovirus (CPV) of pups with maternal antibody, utilizing a modified-live virus (MLV) CPV vaccine having a titer of 10(7) TCID50/dose. This vaccine was shown to be effective also when HI antibody titers of pups were < or = 1:80.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1330425     DOI： 10.1016/0147-9571(92)90007-e

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN： 0147-9571            Impact factor:   2.268


  4 in total

1.  Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies.

Authors:  Vito Martella; Alessandra Cavalli; Nicola Decaro; Gabriella Elia; Costantina Desario; Marco Campolo; Giancarlo Bozzo; Elvira Tarsitano; Canio Buonavoglia
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

2.  Canine parvovirus infection, canine distemper and infectious canine hepatitis: inclination to vaccinate and antibody response in the Swedish dog population.

Authors:  P Olson; A Hedhammar; B Klingeborn
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

3.  Comparative immune responses of pups following modified live virus vaccinations against canine parvovirus.

Authors:  Jayalakshmi Vasu; Mouttou Vivek Srinivas; Prabhakar Xavier Antony; Jacob Thanislass; Vijayalakshmi Padmanaban; Hirak Kumar Mukhopadhyay
Journal:  Vet World       Date:  2019-09

Review 4.  Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication?

Authors:  N Decaro; C Buonavoglia; V R Barrs
Journal:  Vet Microbiol       Date:  2020-06-15       Impact factor: 3.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.